Ritholtz Wealth Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Ritholtz Wealth Management's BIIB Position: Q3 2026 in Review
Ritholtz Wealth Management increased its Biogen (BIIB) stake by 0.07% in Q3 2026, buying an estimated $4.88K and bringing the position to 34,306 shares worth $7.75M. The position accounts for 0.11% of the portfolio, ranked #120.
Ritholtz Wealth Management first reported a position in BIIB in Q2 2020 and has held it in 17 quarters since. 881 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- Ritholtz Wealth Management held 34,306 shares of Biogen worth $7.75M as of Q3 2026.
- Ritholtz Wealth Management bought 23 Biogen shares in Q3 2026, an estimated $4.88K.
- Biogen made up 0.11% of Ritholtz Wealth Management's portfolio in Q3 2026, its #120 holding.
- Ritholtz Wealth Management first reported a position in Biogen in Q2 2020 and has held it in 17 quarters since.
- 881 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on Ritholtz Wealth Management's 13F filing for Q3 2026, filed 5 Nov 2026.